Literature DB >> 21892603

Immunosuppressive properties of mesenchymal stem cells.

Mohamed Abumaree1, Mohammed Al Jumah, Rishika A Pace, Bill Kalionis.   

Abstract

Mesenchymal stem cells (MSC) can be isolated from different adult tissues including bone marrow, adipose tissue, cord blood and placenta. MSCs modulate the immune function of the major immune cell populations involved in alloantigen recognition and elimination, including antigen presenting cells, T cells, B cells and natural killer cells. Many clinical trials are currently underway that employ MSCs to treat human immunological diseases. However, the molecular mechanism that mediates the immunosuppressive effect of MSCs is still unclear and the safety of using MSC in patient needs further confirmation. Here, we review the cytokines that activate MSCs and the soluble factors produced by MSCs, which allow them to exert their immunosuppressive effects. We review the mechanism responsible, at least in part, for the immune suppressive effects of MSCs and highlight areas of research required for a better understanding of MSC immune modulation.

Entities:  

Mesh:

Year:  2012        PMID: 21892603     DOI: 10.1007/s12015-011-9312-0

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  200 in total

1.  Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction.

Authors:  R Rollín; R Alvarez-Lafuente; F Marco; J A Jover; C Hernández-García; C Rodríguez-Navas; L López-Durán; B Fernández-Gutiérrez
Journal:  Osteoarthritis Cartilage       Date:  2007-01-03       Impact factor: 6.576

Review 2.  Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views.

Authors:  Donald G Phinney; Darwin J Prockop
Journal:  Stem Cells       Date:  2007-09-27       Impact factor: 6.277

3.  Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair.

Authors:  Valentina Cirello; Maria Paola Recalcati; Marina Muzza; Stefania Rossi; Michela Perrino; Leonardo Vicentini; Paolo Beck-Peccoz; Palma Finelli; Laura Fugazzola
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

4.  Perivascular multipotent progenitor cells in human organs.

Authors:  Mihaela Crisan; Chien-Wen Chen; Mirko Corselli; Gabriella Andriolo; Lorenza Lazzari; Bruno Péault
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

Review 5.  Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches.

Authors:  Andrea Augello; Tobias B Kurth; Cosimo De Bari
Journal:  Eur Cell Mater       Date:  2010-09-01       Impact factor: 3.942

6.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

Review 7.  Kaposi's sarcoma-associated herpesvirus: a new DNA tumor virus.

Authors:  C Boshoff; Y Chang
Journal:  Annu Rev Med       Date:  2001       Impact factor: 13.739

8.  Human amniotic mesenchymal cells have some characteristics of cardiomyocytes.

Authors:  Peng Zhao; Hirohiko Ise; Minoru Hongo; Masao Ota; Ikuo Konishi; Toshio Nikaido
Journal:  Transplantation       Date:  2005-03-15       Impact factor: 4.939

9.  Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: results of a phase I-II clinical trial.

Authors:  M L Macmillan; B R Blazar; T E DeFor; J E Wagner
Journal:  Bone Marrow Transplant       Date:  2008-10-27       Impact factor: 5.483

10.  Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells.

Authors:  C Boshoff; T F Schulz; M M Kennedy; A K Graham; C Fisher; A Thomas; J O McGee; R A Weiss; J J O'Leary
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

View more
  101 in total

Review 1.  Therapeutic applications of adipose-derived stem cells in cardiovascular disease.

Authors:  Kyle Bruun; Erika Schermer; Anjali Sivendra; Emily Valaik; Reed B Wise; Rana Said; John R Bracht
Journal:  Am J Stem Cells       Date:  2018-10-01

Review 2.  Cell-based approaches to the engineering of vascularized bone tissue.

Authors:  Rameshwar R Rao; Jan P Stegemann
Journal:  Cytotherapy       Date:  2013-08-31       Impact factor: 5.414

3.  EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.

Authors:  Thao M Nguyen; Agnes Arthur; John D Hayball; Stan Gronthos
Journal:  Stem Cells Dev       Date:  2013-06-29       Impact factor: 3.272

4.  Developmental-like bone regeneration by human embryonic stem cell-derived mesenchymal cells.

Authors:  Liisa T Kuhn; Yongxing Liu; Nolan L Boyd; James E Dennis; Xi Jiang; Xiaonan Xin; Lyndon F Charles; Liping Wang; H Leonardo Aguila; David W Rowe; Alexander C Lichtler; A Jon Goldberg
Journal:  Tissue Eng Part A       Date:  2013-10-04       Impact factor: 3.845

5.  Human adipose-derived stromal/stem cells induce functional CD4+CD25+FoxP3+CD127- regulatory T cells under low oxygen culture conditions.

Authors:  Trivia P Frazier; James B McLachlan; Jeffrey M Gimble; Hugh A Tucker; Brian G Rowan
Journal:  Stem Cells Dev       Date:  2014-03-11       Impact factor: 3.272

6.  Prostaglandin EP2 Receptors Mediate Mesenchymal Stromal Cell-Neuroprotective Effects on Dopaminergic Neurons.

Authors:  Juan Andrés Parga; María García-Garrote; Salvador Martínez; Ángel Raya; José Luis Labandeira-García; Jannette Rodríguez-Pallares
Journal:  Mol Neurobiol       Date:  2017-07-17       Impact factor: 5.590

7.  Mesenchymal Stem Cell-Derived Exosomes: New Opportunity in Cell-Free Therapy.

Authors:  Davod Pashoutan Sarvar; Karim Shamsasenjan; Parvin Akbarzadehlaleh
Journal:  Adv Pharm Bull       Date:  2016-09-25

8.  Clinical results and second-look arthroscopic findings after treatment with adipose-derived stem cells for knee osteoarthritis.

Authors:  Yong-Gon Koh; Yun-Jin Choi; Sae-Kwang Kwon; Yong-Sang Kim; Jee-Eun Yeo
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-12-11       Impact factor: 4.342

9.  Distinct Immunoregulatory Mechanisms in Mesenchymal Stem Cells: Role of the Cytokine Environment.

Authors:  Vladimir Holan; Barbora Hermankova; Pavla Bohacova; Jan Kossl; Milada Chudickova; Michaela Hajkova; Magdalena Krulova; Alena Zajicova; Eliska Javorkova
Journal:  Stem Cell Rev Rep       Date:  2016-12       Impact factor: 5.739

10.  Manufacturing mesenchymal stromal cells for phase I clinical trials.

Authors:  Patrick J Hanley; Zhuyong Mei; Maria da Graca Cabreira-Hansen; Mariola Klis; Wei Li; Yali Zhao; April G Durett; Xingwu Zheng; Yongping Wang; Adrian P Gee; Edwin M Horwitz
Journal:  Cytotherapy       Date:  2013-04       Impact factor: 5.414

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.